Skip to main content
PMC home page
Age logoLink to Age
. 1997 Jul;20(3):165–168. doi: 10.1007/s11357-997-0015-z

Effects of the antioxidant turmeric on lipoprotein peroxides: Implications for the prevention of atherosclerosis

A Ramirez Bosca 1, M A Carrión Gutierrez 1, A Soler 2, C Puerta 3, A Diez 4, E Quintanilla 1, A Bernd 5, J Miquel 4,6,✉
PMCID: PMC3455890  PMID: 23604308

Abstract

Extracts from the rhyzome of Curcuma longa are widely used as food additives in India and other Asiatic and Central American countries. It has been shown that these extracts (“turmeric”), as well as “curcumin” and related phenolic compounds isolated from Curcuma, have a powerful antioxidant action when tested in in vitro systems. Moreover, previous research from our laboratories has shown significant decreases in the levels of lipid peroxides in the blood of both mice and human subjects administered “turmeric.” Our present research complements the previous data, showing that a daily intake of turmeric equivalent to 20 mg of the phenolic antioxidant curcumin for 60 days decreases the high levels of peroxidation of both the HDL and the LDL, in vivo, in 30 healthy volunteers ranging in age from 40 to 90 years. The effect was quite striking in the persons with high baseline values of peroxidized compounds in these lipoproteins, while no apparent change took place in the persons having low baseline values.

In view of current concepts on the atherogenic role played by peroxidized HDL, and especially by peroxidized LDL, as inducers of foam and smooth cell proliferation in the arterial wall, this preliminary experiment suggests that the Curcuma phenolic antioxidants, because of their high antioxidant activity and lack of toxicity, might be a useful complement to standard hypo-lipidemic drugs in the prevention and treatment of atherosclerosis.

Keywords: Atherosclerosis, atherogenesis, lipoperoxides, LDL, turmeric, curcuma

Full Text

The Full Text of this article is available as a PDF (345.0 KB).

References

  • 1.Cummins E.M., Hayward M.D., Saito S. Differentials in active life expectancy in the older population of the United States. J. Gerontol., Social Sciences. 1996;51B:S111–120. doi: 10.1093/geronb/51b.3.s111. [DOI] [PubMed] [Google Scholar]
  • 2.Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 1956;11:298–300. doi: 10.1093/geronj/11.3.298. [DOI] [PubMed] [Google Scholar]
  • 3.Harman D. Free radical theory of aging: role of free radicals in the origination and evolution of life, aging and disease processes. In: Johnson J. E. Jr., Walford R., Harman D., Miquel J., editors. Free Radicals, Aging and Degenerative Diseases. New York: Alan R Liss; 1986. pp. 3–49. [Google Scholar]
  • 4.Zs.-Nagy I. A membrane hypothesis of aging. J. Theoret. Biol. 1978;75:189–195. doi: 10.1016/0022-5193(78)90230-8. [DOI] [PubMed] [Google Scholar]
  • 5.Harman D. The biological clock: the mitochondria? J. Am. Geriatr. Soc. 1972;20:145–147. doi: 10.1111/j.1532-5415.1972.tb00787.x. [DOI] [PubMed] [Google Scholar]
  • 6.Miquel J., Economos A.C., Fleming J., Bensch K.G., Atlan H., Johnson J.E., Jr. Mitochondrial role in cell aging. Exptl. Gerontol. 1980;15:575–591. doi: 10.1016/0531-5565(80)90010-8. [DOI] [PubMed] [Google Scholar]
  • 7.Fleming J.E., Miquel J., Cottrell L.S., Yengoyan L.S. Is cell aging caused by respiration-dependent injury to the mitochondrial genome? Gerontology. 1982;28:44–53. doi: 10.1159/000212510. [DOI] [PubMed] [Google Scholar]
  • 8.Miquel J. An update on the mitochondrial-DNA mutation hypothesis of cell aging. Mutation Res. 1992;275:209–216. doi: 10.1016/0921-8734(92)90024-J. [DOI] [PubMed] [Google Scholar]
  • 9.Harman D. Free radical theory of aging: nutritional implications. Age. 1978;1:145–152. doi: 10.1007/BF02432188. [DOI] [Google Scholar]
  • 10.Weber H., Miquel J. Antioxidant supplementation and longevity. In: Chen L., editor. Nutritional Aspects of Aging. Boca Raton: CRC Press; 1986. pp. 42–49. [Google Scholar]
  • 11.De la Fuente M., Ferrandez D., Muñoz F., De Juan E., Miquel J. Stimulation by the antioxidant thioproline of the lymphocyte functions of old mice. Mech. Ageing Dev. 1993;68:27–36. doi: 10.1016/0047-6374(93)90137-G. [DOI] [PubMed] [Google Scholar]
  • 12.Miquel J., Martínez M., Diez A., De Juan E., Soler A., Ramirez A., Laborda J., Carrión M. Effects of turmeric on blood and liver lipoperoxide levels of mice: lack of toxicity. Age. 1995;18:171–174. [Google Scholar]
  • 13.Ramirez-Boscá A., Soler A., Carrión Gutiérrez M.A., Laborda Alvarez A., Quintanilla Almagro E. Antioxidant curcuma extracts decrease the blood lipid peroxide levels of human subjects. Age. 1995;18:167–169. [Google Scholar]
  • 14.Azuine M.A., Bhide S.V. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer. 1992;17:77–83. doi: 10.1080/01635589209514174. [DOI] [PubMed] [Google Scholar]
  • 15.Soni K.B., Rajan A., Juttan R. Reversal of aflatoxin-induced liver damage by turmeric and curcumin. Cancer Letters. 1992;66:115–121. doi: 10.1016/0304-3835(92)90223-I. [DOI] [PubMed] [Google Scholar]
  • 16.Toda S. Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma Longa L. Chem. Pharm. Bull. 1985;33:1725–1728. doi: 10.1248/cpb.33.1725. [DOI] [PubMed] [Google Scholar]
  • 17.Masuda T., Isobe J., Jitoe A., Nakatani N. Antioxidative curcuminoids from rhizomes of Curcuma xantorrhyza. Phytochemistry. 1992;31:3645–3647. doi: 10.1016/0031-9422(92)83748-N. [DOI] [Google Scholar]
  • 18.Jitoe A., Masuda T., Tengah I.G.P., Suprapta D.N., Gara I.W., Nakatani N. Antioxidant activity of tropical ginger extracts and analysis of the contained curcuminoids. J. Agrc. Food Chem. 1992;40:1337–1340. doi: 10.1021/jf00020a008. [DOI] [Google Scholar]
  • 19.Sharma O.P. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol. 1976;25:1811–1812. doi: 10.1016/0006-2952(76)90421-4. [DOI] [PubMed] [Google Scholar]
  • 20.Henning B., Chow C.K. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Rad. Biol. Med. 1988;4:99–106. doi: 10.1016/0891-5849(88)90070-6. [DOI] [PubMed] [Google Scholar]
  • 21.Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990’s. Nature. 1993;362:801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  • 22.Povear, H., Santos, C., Gammaro, R., Camara, M., and Oliveira Lima, A.: Peroxidized LDL: a new risk factor in atherosclerosis. Presented at the “International Congress on Free Radicals and Aging,” Paris, 26–28 September 1991.
  • 23.Ohkava M., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979;95:351–358. doi: 10.1016/0003-2697(79)90738-3. [DOI] [PubMed] [Google Scholar]
  • 24.Harman D. Atherosclerosis: oxidation of serum lipoproteins and its relationship to pathogenesis. Clin Res. 1960;8:108. [Google Scholar]
  • 25.Yagi K., Ohkawa H., Ohishi N., Yamashita M., Nakashima T. Lesion of aortic intima caused by intravenous administration of linoleic acid hydroperoxide. J. Appl. Biochem. 1981;3:58–67. [Google Scholar]
  • 26.Yagi K. Serum lipid peroxide levels in subjects having certain diseases and aging. In: Miquel J., Quintanilha A., Weber H., editors. CRC Handbook of Free Radicals and Antioxidants in Biomedicine. Boca Ratón: CRC Press; 1989. pp. 223–230. [Google Scholar]
  • 27.Santos M. T., Valles J., Aznar J. Plasma lipid peroxides in patients with vascular disease and in middle-aged normal subjects with a high risk of atherosclerosis. In: Miquel J., Quintanilha A., Weber H., editors. CRC Handbook of Free Radicals and Antioxidants in Biomedicine. Boca Raton: CRC Press; 1989. pp. 237–254. [Google Scholar]
  • 28.Mitchinson M.J. Macrophages, oxidized lipids and atherosclerosis. Med. Hypotheses. 1983;12:171–178. doi: 10.1016/0306-9877(83)90079-8. [DOI] [PubMed] [Google Scholar]
  • 29.Carpenter K.L.H., Wilkins G.M., Fussele B. Production of oxidized lipids during modification of low-density lipoprotein by macrophages or copper. Biochem. J. 1994;304:625–633. doi: 10.1042/bj3040625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Holvoet P., Collen D. Oxidized lipoproteins in atherosclerosis and thrombosis. FASEB J. 1994;8:1279–1284. doi: 10.1096/fasebj.8.15.8001740. [DOI] [PubMed] [Google Scholar]
  • 31.Johnson E.J. Aging and carotene nutriture. Age. 1993;16:59–66. [Google Scholar]
  • 32.Rimm E.B. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 1993;328:1450–1456. doi: 10.1056/NEJM199305203282004. [DOI] [PubMed] [Google Scholar]
  • 33.Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS) The Lancet. 1996;347:781–786. doi: 10.1016/S0140-6736(96)90866-1. [DOI] [PubMed] [Google Scholar]
  • 34.Faramarz A., Suzuki S., Hua-Zhou J., Isshiki N., Miyachi Y. Involvement of lipid peroxidation in necrosis of skin flaps and its suppression by ellagic acid. Plast. Reconstr. Surg. 1994;94:1027–1035. doi: 10.1097/00006534-199412000-00018. [DOI] [PubMed] [Google Scholar]

Articles from Age are provided here courtesy of American Aging Association

RESOURCES